Indeed, several transcription enhancers tether transcriptionally active loci to the NPC, and also promote large-scale gene–NPC interactions in cancer cells [14], highlighting the direct correlation among enhancers–chromatin–NPC [15], which also provides potential therapeutic targets for CRC. The gene discussed is NPC1; the disease is colorectal carcinoma.